Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference   NEW YORK – September 9, 2021 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other…